Specialty Generics Market Size & Analysis - Forecasts to 2026

As per the research conducted by GME, the Specialty Generics Market will grow with a CAGR value of 12 percent by 2026. Increasing availability of non-exclusive specialty generic medicines, multiple considerations such as early patent expirations of key drugs in the market, as well as the growth and acceptance of off-patent specialty generics as a novel entrant, are presumed to fuel demand for specialty generics throughout the forecast period.

Browse 151 Market Data Tables and 111 Figures spread through 181 Pages and in-depth TOC on “Specialty Generics Market - Forecast to 2026" https://www.globalmarketestimates.com/market-report/global-specialty-generics-market-3143

By Type (Injectables, Oral, Parenteral, Topical, and Others), By Application (Oncology, Inflammatory Conditions, Multiple Sclerosis, and Hepatitis C), By End-Use (Specialty Pharmacy, Retail Pharmacy, and Hospital Pharmacy), By Region (North America, Asia Pacific, CSA, Europe, and The Middle East and Africa); End-User Landscape, Company Market Share Analysis, and Competitor Analysis
Key Market Insights
• The global specialty generics market is influenced by legislative policies and regulations that aid in the manufacture of specialty generics in various nations.
• The injectable is foreseen to dominate in the type segment. This is attributed to the expanding use of self-monitored injectables by patients.
• Oncology is presumed to lead in the application segment due to the rising prevalence of cancer cases globally.
• The specialty pharmacy is likely to dominate in the end-use segment due to the development of novel therapeutics for the management of a variety of chronic diseases.
• North America predominates in the global market because healthcare organizations such as WHO are majorly active in policy formulation, such as National Cancer Control Programmes.
• Mylan N.V., Teva Pharmaceuticals, Inc., Sandoz International GmbH, Mallinckrodt, Akorn, Inc., Valeant Pharmaceuticals International, Inc., Endo Pharmaceuticals, Inc., Pfizer, Inc., Sun Pharmaceutical Industries Ltd., and Apotex Corp. are the major players in the specialty generics market.

Browse the Report @ https://www.globalmarketestimates.com/market-report/global-specialty-generics-market-3143

Type Outlook (Revenue, USD Billion, 2021-2026)
• Injectables
• Oral
• Parenteral
• Topical
• Others

Application Outlook (Revenue, USD Billion, 2021-2026)
• Oncology
• Inflammatory Conditions
• Multiple Sclerosis
• Hepatitis C

End-Use Outlook (Revenue, USD Billion, 2021-2026)
• Specialty Pharmacy
• Retail Pharmacy
• Hospital Pharmacy

Regional Outlook (Revenue, USD Billion, 2021-2026)
North America
• The U.S.
• Canada
• Mexico
Europe
• Germany
• UK
• France
• Spain
• Italy
• Rest of Europe
Asia Pacific
• China
• India
• Japan
• South Korea
• Australia
• Rest of APAC
Central & South America
• Brazil
• Argentina
• Rest of CSA
Middle East & Africa
• Saudi Arabia
• UAE
• Rest of MEA

Contact: Yash Jain
Email address: yash.jain@globalmarketestimates.com
Phone Number: +16026667238
Website: https://www.globalmarketestimates.com/
Check our Latest Blogs: https://www.globalmarketestimates.com/blog-posts.php

B-502, Kemp Plaza, Mindspace, Malad West, Mumbai: 400 064, India

Global Market Estimates is an India based market research and consulting company. The company provides syndicated research reports, customised research reports and consulting services to their clients and helps them achieve their business goals on a commercial level. Global Market Estimates database is used by the world's well known and prolific academic institutions and Fortune 500 companies to understand the global and regional business environment to excel in their business goals.

This release was published on openPR.